Vir Biotechnology
VIR
VIR
61 hedge funds and large institutions have $1.3B invested in Vir Biotechnology in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
1.13% more ownership
Funds ownership: 33.36% → 34.49% (+1.1%)
Holders
61
Holding in Top 10
3
Calls
$699K
Puts
$342K
Top Buyers
| 1 | +$9.27M | |
| 2 | +$5.71M | |
| 3 | +$3.8M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.15M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.93M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$12.7M | |
| 3 | -$8.57M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$941K |
| 5 |
Blackstone Inc
New York
|
-$440K |